Skip to main navigation Skip to search Skip to main content

Prescribing electroconvulsive therapy for depression: Not as simple as it used to be

  • Shane Gill*
  • , Salam Hussain
  • , Subramanian Purushothaman
  • , Shanthi Sarma
  • , Alan Weiss
  • , Suneel Chamoli
  • , Matthew Fasnacht
  • , Ashu Gandhi
  • , Paul B. Fitzgerald
  • , Brett Simpson
  • , Colleen K. Loo
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

Abstract

In the last century, prescribing electroconvulsive therapy usually involved considering the relative merits of unilateral versus bilateral electroconvulsive therapy, with most other parameters fixed. However, research over the last 30 years has discovered that several parameters of the electroconvulsive therapy stimulus can have a significant impact on efficacy and cognitive side effects. The stimulus dose relative to seizure threshold was shown to significantly affect efficacy, especially for right unilateral electroconvulsive therapy, where suprathreshold doses in the vicinity of 5–6 times seizure threshold were far more efficacious than doses closer to threshold. However, this did not hold for bitemporal electroconvulsive therapy, where near-threshold stimuli were equally effective as suprathreshold stimuli. Then, changes in stimulus pulse width were found to also have a significant impact on both efficacy and side effects, with ultrabrief pulse widths of 0.3 ms having significantly fewer cognitive side effects in unilateral electroconvulsive therapy than standard brief pulse widths of 1.0 ms, with only slightly reduced efficacy. Therefore, choosing the optimum electroconvulsive therapy prescription for an individual patient now requires consideration of placement, pulse width and stimulus dose relative to seizure threshold, and how these three interact with each other. This viewpoint aims to raise awareness of these issues for psychiatrists involved in electroconvulsive therapy practice.

Original languageEnglish
Pages (from-to)1202-1207
Number of pages6
JournalAustralian and New Zealand Journal of Psychiatry
Volume57
Issue number9
DOIs
Publication statusPublished - Sept 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Prescribing electroconvulsive therapy for depression: Not as simple as it used to be'. Together they form a unique fingerprint.

Cite this